اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA)  استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA  می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است
ADDERALL 10 از شرکت TEVA WOMENS
   New Drug Application (NDA): 011522
    
Company: TEVA WOMENS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS | 
|---|---|---|---|---|---|---|---|
| ADDERALL 10 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 2.5MG;2.5MG;2.5MG;2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued | 
 None  | 
Yes | No | 
| ADDERALL 12.5 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 3.125MG;3.125MG;3.125MG;3.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued | 
 None  | 
Yes | No | 
| ADDERALL 15 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 3.75MG;3.75MG;3.75MG;3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued | 
 None  | 
Yes | No | 
| ADDERALL 20 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 5MG;5MG;5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued | 
 None  | 
Yes | No | 
| ADDERALL 30 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 7.5MG;7.5MG;7.5MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued | 
 None  | 
Yes | No | 
| ADDERALL 5 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 1.25MG;1.25MG;1.25MG;1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued | 
 None  | 
Yes | No | 
| ADDERALL 7.5 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 1.875MG;1.875MG;1.875MG;1.875MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued | 
 None  | 
Yes | No | 
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url | 
|---|---|---|---|---|---|---|---|
| 01/19/1960 | ORIG-1 | Approval | 
 Type 2 New Active Ingredient and Type 4 New Combination  | 
 STANDARD  | 
 
 
  | 
 Label is not available on this site.  | 
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url | 
|---|---|---|---|---|---|
| 01/04/2017 | SUPPL-43 | Labeling-Package Insert | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/011522s043lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/011522Orig1s043ltr.pdf  | 
||
| 10/01/2015 | SUPPL-42 | Labeling-Package Insert | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011522s042lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/011522Orig1s042ltr.pdf  | 
||
| 04/17/2015 | SUPPL-41 | Labeling-Package Insert | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011522s041lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/011522Orig1s041ltr.pdf  | 
||
| 06/07/2007 | SUPPL-40 | Labeling | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011522s040lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/011522s040ltr.pdf  | 
||
| 07/26/2006 | SUPPL-37 | Labeling | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011522s034s037,021303s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/011522s034, 037, 021303s013LTR.pdf  | 
||
| 07/26/2006 | SUPPL-34 | Labeling | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011522s034s037,021303s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/011522s034, 037, 021303s013LTR.pdf  | 
||
| 08/02/2005 | SUPPL-33 | Labeling | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/011522s032,033lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/011522s032,033ltr.pdf  | 
||
| 08/02/2005 | SUPPL-32 | Labeling | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/011522s032,033lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/011522s032,033ltr.pdf  | 
||
| 11/08/2002 | SUPPL-30 | Manufacturing (CMC)-Formulation | 
 Label is not available on this site.  | 
 https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/11522scf030ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/11-522S030_Adderall.cfm  | 
|
| 04/11/2002 | SUPPL-29 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 12/10/2001 | SUPPL-28 | Manufacturing (CMC)-Control | 
 Label is not available on this site.  | 
||
| 07/24/2000 | SUPPL-27 | Manufacturing (CMC)-Control | 
 Label is not available on this site.  | 
||
| 08/31/2000 | SUPPL-26 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 02/15/2000 | SUPPL-25 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 01/26/2000 | SUPPL-24 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 09/20/1999 | SUPPL-23 | Manufacturing (CMC)-Control | 
 Label is not available on this site.  | 
||
| 11/12/1999 | SUPPL-22 | Manufacturing (CMC)-Control | 
 Label is not available on this site.  | 
||
| 05/21/1999 | SUPPL-21 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 02/23/1999 | SUPPL-20 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 03/16/1998 | SUPPL-19 | Manufacturing (CMC)-Control | 
 Label is not available on this site.  | 
||
| 01/08/1998 | SUPPL-18 | Manufacturing (CMC)-Control | 
 Label is not available on this site.  | 
||
| 07/25/1997 | SUPPL-17 | Labeling | 
 Label is not available on this site.  | 
||
| 11/14/1997 | SUPPL-16 | Manufacturing (CMC)-Control | 
 Label is not available on this site.  | 
||
| 07/17/1997 | SUPPL-15 | Labeling | 
 Label is not available on this site.  | 
||
| 06/13/1997 | SUPPL-14 | Manufacturing (CMC)-Control | 
 Label is not available on this site.  | 
||
| 05/12/1997 | SUPPL-13 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 01/29/1997 | SUPPL-12 | Manufacturing (CMC)-Control | 
 Label is not available on this site.  | 
||
| 07/17/1997 | SUPPL-11 | Labeling | 
 Label is not available on this site.  | 
||
| 02/13/1996 | SUPPL-10 | Manufacturing (CMC)-Formulation | 
 Label is not available on this site.  | 
 https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/11522S010_Adderall.pdf  | 
|
| 02/13/1996 | SUPPL-9 | Labeling | 
 Label is not available on this site.  | 
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert  | 
Note | Url | 
|---|---|---|---|---|---|
| 01/04/2017 | SUPPL-43 | 
 Labeling-Package Insert  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/011522s043lbl.pdf | |
| 10/01/2015 | SUPPL-42 | 
 Labeling-Package Insert  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011522s042lbl.pdf | |
| 04/17/2015 | SUPPL-41 | 
 Labeling-Package Insert  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011522s041lbl.pdf | |
| 06/07/2007 | SUPPL-40 | 
 Labeling  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011522s040lbl.pdf | |
| 07/26/2006 | SUPPL-37 | 
 Labeling  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011522s034s037,021303s013lbl.pdf | |
| 07/26/2006 | SUPPL-34 | 
 Labeling  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011522s034s037,021303s013lbl.pdf | |
| 08/02/2005 | SUPPL-33 | 
 Labeling  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/011522s032,033lbl.pdf | |
| 08/02/2005 | SUPPL-32 | 
 Labeling  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/011522s032,033lbl.pdf | 
                
                  
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
نظرات کاربران